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An 85-year-old white man with known history of mela-noma was referred to the Interventional Pulmonary ser-
vice for hemoptysis. Review of recent imaging revealed
nodular infiltrates without significant volume loss. Bronchos-
copy was performed revealing glistening polypoid endobron-
chial masses obstructing the apical-posterior segment (B 12)
of the left upper lobe and anterior segment of the right upper
lobe (B3) (Figure 1). Bronchoscopic needle aspiration and
biopsy were performed. Argon plasma coagulation was then
undertaken with successful ablation and subsequent patency
of the involved segments (Figure 2).
Lung metastases from malignancy other than broncho-
genic carcinoma are a common occurrence with the incidence
ranging from 20 to 50%.1 Although the incidence for endo-
bronchial metastasis has been reported to be from about 2 to
28%, a retrospective review of 1359 autopsies revealed only
2% of patients dying with solid tumors to have metastatic
involvement of the central airways.2 Metastases from primary
malignancy are traditionally described to spread via a hema-
togenous or lymphatic route, however, tracheal or bronchial
obstruction due to endobronchial metastasis is rare, and must
be differentiated from obstruction caused by an extrinsic
mass. Although frequently asymptomatic (52%), endoluminal
metastasis may commonly present with cough, wheezing,
dyspnea, and hemoptysis as was present in our patient.
Radiographic findings may include lobar or segmental atel-
ectasis. Endoluminal metastasis may signal slow disease
progression and have a median lag time of up to 5 years or
more dependent upon the underlying primary malignancy.3
Renal cell carcinoma is thought to be the most frequent
etiology of endobronchial metastasis with other tumors to
include melanoma, lymphoma, breast, larynx, thyroid, and
colon. Primary melanoma of the airway with tracheal ob-
struction and diffuse melanosis of the airways without asso-
ciated skin or mucous membrane pigmentation has also been
described. Rare patients with bronchial obstruction associated
with malignant melanoma have been reported, as was true in
our patient. Appropriate diagnosis should be performed to
exclude the potential of a second primary. Endobronchial
biopsies are easily obtained, however, as certain tumors are
noted for a propensity toward significant bleeding, such as
renal cell carcinoma and melanoma, initial sampling may
easily be performed by means of endoluminal needle aspira-
tion described by Wang et al.4 Management of bronchial
metastases is symptom based. Historically, if the obstructing
mass could be localized by imaging studies, external beam
radiotherapy, or surgery was employed to palliate the ob-
struction. It is currently reasonable to attempt to relieve
obstruction by laser endoscopy, argon coagulation, or photo-
dynamic therapy. Endobronchial brachytherapy has some-
times been attempted with some success although late toxic-
ity with bronchial wall necrosis has been attributed to contact
between the catheter and bronchial wall mucosa. It should be
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FIGURE 1. Metastatic melanoma presenting as obstructing
endobronchial polypoid mass.
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noted that the intent of such treatment is to palliate symp-
toms, as overall prognosis of the patient is determined by the
nature of the neoplasm causing bronchial metastasis. Pallia-
tion of lung symptoms may improve performance status
enough to allow more aggressive systemic therapy.
In summary, the potential for endobronchial metastasis
in patients with melanoma should be investigated in those
patients with new or worsening pulmonary symptoms and
signs. Further investigation into molecular markers for help
in the characterization of which patients may have an in-
creased incidence for such metastasis should be considered.
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FIGURE 2. Patent segmental bronchus subsequent to ar-
gon plasma coagulation ablation.
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